2.28BMarket Cap
LossP/E TTM
BioCryst Pharmaceuticals Inc
BCRX Balance Sheet
You can check out the annual or quarterly balance sheets of BioCryst Pharmaceuticals Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing BCRX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does BioCryst Pharmaceuticals Inc Have?
In its most recent quarterly, BioCryst Pharmaceuticals Inc had 171.59M in cash and cash equivalents.
How Much Are BioCryst Pharmaceuticals Inc's Total Liabilities?
BioCryst Pharmaceuticals Inc reported 633.31M in total liabilities as of the latest reported quarter, including 196.07M in current liabilities and 437.25M in non-current liabilities.
What Are BioCryst Pharmaceuticals Inc's Total Assets?
As of the latest reported quarter, BioCryst Pharmaceuticals Inc's total assets were 514.16M, consisting of 404.35M in current assets and 109.81M in non-current assets.
How Much Shareholders' Equity Does BioCryst Pharmaceuticals Inc Have?
BioCryst Pharmaceuticals Inc reported -119.15M in total shareholders' equity as of the latest reported quarter.